129 related articles for article (PubMed ID: 9441842)
1. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
Pechánová O; Bernátová I; Pelouch V; Simko F
J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
[TBL] [Abstract][Full Text] [Related]
2. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
Bernátová I; Pechánová O; Pelouch V; Simko F
J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
[TBL] [Abstract][Full Text] [Related]
3. Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney.
Bernátová I; Pechánová O; Simko F
Exp Physiol; 1999 Nov; 84(6):1095-105. PubMed ID: 10564706
[TBL] [Abstract][Full Text] [Related]
4. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
[TBL] [Abstract][Full Text] [Related]
5. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
[TBL] [Abstract][Full Text] [Related]
6. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
Bernátová I; Pechánová O; Simko F
Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
[TBL] [Abstract][Full Text] [Related]
7. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
[TBL] [Abstract][Full Text] [Related]
8. Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition.
Simko F; Pelouch V; Torok J; Luptak I; Matuskova J; Pechanova O; Babal P
J Biomed Sci; 2005; 12(1):103-11. PubMed ID: 15864743
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
10. Effects of captopril on cardiac and renal damage, and metabolic alterations in the nitric oxide-deficient hypertensive rat.
Khattab MM; Mostafa A; Al-Shabanah O
Kidney Blood Press Res; 2005; 28(4):243-50. PubMed ID: 16220007
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
12. Effect of captopril on cyclic nucleotide concentrations during long-term NO synthase inhibition.
Pechánová O; Bernátová I
Physiol Res; 2000; 49(1):55-63. PubMed ID: 10805405
[TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
Rossi MA; Ramos SG; Prado CM
J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
[TBL] [Abstract][Full Text] [Related]
14. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
16. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
[TBL] [Abstract][Full Text] [Related]
18. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
19. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
Pereira LM; Bezerra DG; Machado DL; Mandarim-de-Lacerda CA
Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
[TBL] [Abstract][Full Text] [Related]
20. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
